Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01142674 · ClinicalTrials.gov registry record
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
A clinical trial of Lymphoma, T-Cell, Peripheral, sponsored by Associazione Angela Serra per la ricerca sul cancro.
- Completed
- Registry status
- 1,650
- Enrollment target
- 20
- Study locations
NCT01142674 is a study of Lymphoma, T-Cell, Peripheral that has completed, run by Associazione Angela Serra per la ricerca sul cancro. The registered enrollment target is 1,650 participants, above the 58-participant average among 6 other Lymphoma, T-Cell, Peripheral trials with a reported enrollment target (2745% higher). The trial reports 20 study locations across 11 states.
The verdict
NCT01142674, a study of Lymphoma, T-Cell, Peripheral, has completed, sponsored by Associazione Angela Serra per la ricerca sul cancro.
- COMPLETED
- Registry status
- 1,650 participants
- Enrollment target
- 20
- Study locations
Study Summary
The designed study follows up the retrospective previous one by the International T-cell Non-Hodgkin's Lymphoma Study Group (International Peripheral T-Cell Lymphoma Project). It is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed patients with the more frequent subtypes of Peripheral T-cell lymphoma (Peripheral T-cell lymphoma unspecified and Angioimmunoblastic T-cell lymphoma) and to better define clinical characteristics and outcome of the more uncommon subtypes
Conditions Studied
Study Locations (20)
Other
- Fundacion Fundaleu - Buenos Aires
- Santa Casa Medical School - São Paulo
- Hospital del Salvador SSMO - Santiago
- Princess Margaret Hospital - Hong Kong
- Queen Mary Hospital - Hong Kong
- Tuen Mun Hospital - Hong Kong
- Hopital St Louis - Paris
- Sheba Medical Center - Tel Aviv
- Sourasky Medical Center - Tel Aviv
Buenos Aires
- Hospital Italiano - La Plata
- Hospital San Martìn - La Plata
California
- Stanford University Medical Center - Palo Alto
Connecticut
- Yale Cancer Center - New Haven
Missouri
- St Louis Washington University - St Louis
Nebraska
- University of Nebraska Medical Center - Omaha
New York
- Memorial Sloan-Kettering Cancer Center - New York
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,650 participants |
| Start Date | 2006-09 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01142674
The ClinicalTrials.gov registry entry for NCT01142674 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,650 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 58-participant average among 6 other Lymphoma, T-Cell, Peripheral trials with a reported enrollment target (2745% higher). The listed sponsor is Associazione Angela Serra per la ricerca sul cancro, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphoma, T-Cell, Peripheral appearing as the primary indexed condition, and to 0 interventions.
NCT01142674 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, Buenos Aires, California.
Frequently Asked Questions
What is clinical trial NCT01142674 about?
NCT01142674 is a clinical study titled "T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma". The designed study follows up the retrospective previous one by the International T-cell Non-Hodgkin's Lymphoma Study Group (International Peripheral T-Cell Lymphoma Project). It is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed pa...
What is the current status of trial NCT01142674?
This trial is currently completed. The enrollment target is 1,650 participants. The study started on 2006-09. Estimated completion is 2018-12.
What conditions does trial NCT01142674 study?
This clinical trial studies the following conditions: Lymphoma, T-Cell, Peripheral.
Who is sponsoring clinical trial NCT01142674?
This trial is sponsored by Associazione Angela Serra per la ricerca sul cancro, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01142674 being conducted?
This trial has 20 study locations across California, Connecticut, Missouri, Nebraska, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma, T-Cell, Peripheral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RECRUITING · Phase 3
-
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
RECRUITING · Phase 1
-
A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers
ACTIVE NOT RECRUITING · Phase 1
-
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
ACTIVE NOT RECRUITING · Phase 1
-
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma
COMPLETED · Phase 1
-
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.